Adopt blockchain-based pharma solutions to ensure higher quality control across value chain: OPPI, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

Issuing a statement on the cancellation of licences for 18 pharma companies, Vivek Sehgal, Director General, Organisation of Pharmaceutical Producers of India (OPPI) shared, “Any violation of good manufacturing practices (GMP) is a public health hazard. It is important to ensure patients can access breakthrough innovations while upholding ethical codes and maintaining strict regulatory standards. This is crucial to maintain patient safety and trust.”, Issuing a statement on the cancellation of licences for 18 pharma companies, Vivek Sehgal, Director General, Organisation of Pharmaceutical Producers of India (OPPI) shared, “Any violation of good manufacturing practices (GMP) is a public health hazard. It is important to ensure patients can access breakthrough innovations while upholding ethical codes and maintaining strict regulatory standards. This is crucial to maintain patient safety and trust.”, , Read More